NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop lung cancer from returning
Disease control OngoingThis study tests whether adding the drug durvalumab to targeted radiation (SBRT) can help keep early-stage non-small cell lung cancer from coming back. It included 13 people with stage I to IIIA disease. The main goal was to see how long they lived without their cancer getting wo…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
No-Marker tumor tracking could make lung cancer radiation safer
Knowledge-focused OngoingThis study tests a new X-ray technique to track lung tumors during radiation without needing implanted markers. Five adults with early-stage lung cancer will be observed to see if the markerless method matches the standard marker-based tracking within 3 millimeters. If it works, …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Sponsor: Royal North Shore Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC